CRISPR-Cas gene editing technology in biomanufacturing to enhance stress tolerance of microbial strains
FEMS Microbiology Letters · 07.01.2026 · 373
DOI: 10.1093/femsle/fnag030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEMS Microbiology Letters, online erschienen am 24.03.2026. Verfasst von Hongmin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Stress, Physiological, Industrial Microbiology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Postdoctoral Research Program of Shaanxi, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
In response to the loss of microbial efficiency caused by environmental stress in biomanufacturing, CRISPR-Cas gene editing technology has become a core tool for enhancing stress tolerance by accurately targeting genomic loci. This article systematically reviews the progress of its application. By optimizing engineered nucleases, gRNA design, and innovative delivery strategies, this technology successfully regulates key pathways in oxidative stress responses. It integrates functional genome screening with dynamic regulation to examine the networks of multi-gene collaborative tolerance. In the construction of high-stress-tolerant industrial chassis cells, the stress survival rate (>90% in Bacillus subtilis under thermal stress) and product synthesis ability (such as cellulose producing ethanol up to 4.5 g/l) of strains such as Escherichia coli and Corynebacterium glutamicum were significantly improved. Current challenges focus on delivery efficiency, off-target risks, and complex regulatory bottlenecks. In the future, the development of new editing tools and intelligent circuits will promote their industrial application in sustainable biomanufacturing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an 710061, China.
- Nuclear Industry 215 Hospital of Shaanxi Province, Xianyang 712000, China.
- School of Physical Education, Xi'an Jiaotong University, Xi'an 710049, China.
- Department of Human Anatomy and Histology and Embryology, School of Basic Medical Science, Xi'an Jiaotong University, Xi'an 710061, China.
- College of Food Science and Engineering, Xinyang Agriculture and Forestry University, Xinyang 464399, China.
- Department of Functional Examination, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
ORCID-Profile: Dingkang Wang
Förderung
- China Postdoctoral Science Foundation
- Postdoctoral Research Program of Shaanxi
- Postdoctoral Fellowship Program of CPSF
- Natural Science Basis Research Plan in Shaanxi Province of China
- National Training Program of Innovation and Entrepreneurship for Undergraduates
- CSC
Zitieren
APA
Zhang, H., Liu, L., Wang, D., Yang, X., Kang, Y., Huang, J., Ouyang, Y., Yu, H., & Zhang, Y. (2026). CRISPR-Cas gene editing technology in biomanufacturing to enhance stress tolerance of microbial strains. FEMS Microbiology Letters, 373. https://doi.org/10.1093/femsle/fnag030
Vancouver
Zhang H, Liu L, Wang D, Yang X, Kang Y, Huang J, et al. CRISPR-Cas gene editing technology in biomanufacturing to enhance stress tolerance of microbial strains. FEMS Microbiology Letters. 2026;373. doi:10.1093/femsle/fnag030
BibTeX
@article{Zhang2026,
author = {Zhang, Hongmin and Liu, Lerong and Wang, Dingkang and Yang, Xinya and Kang, Yiting and Huang, Jing and Ouyang, Yuanshuo and Yu, Hongfei and Zhang, Yongjie},
title = {CRISPR-Cas gene editing technology in biomanufacturing to enhance stress tolerance of microbial strains},
journal = {FEMS Microbiology Letters},
year = {2026},
volume = {373},
doi = {10.1093/femsle/fnag030}
}
EUVIMED